50 related articles for article (PubMed ID: 28923245)
21. Shared pathways of IkappaB kinase-induced SCF(betaTrCP)-mediated ubiquitination and degradation for the NF-kappaB precursor p105 and IkappaBalpha.
Heissmeyer V; Krappmann D; Hatada EN; Scheidereit C
Mol Cell Biol; 2001 Feb; 21(4):1024-35. PubMed ID: 11158290
[TBL] [Abstract][Full Text] [Related]
22. Mechanisms of ubiquitin-mediated, limited processing of the NF-kappaB1 precursor protein p105.
Ciechanover A; Gonen H; Bercovich B; Cohen S; Fajerman I; Israël A; Mercurio F; Kahana C; Schwartz AL; Iwai K; Orian A
Biochimie; 2001; 83(3-4):341-9. PubMed ID: 11295495
[TBL] [Abstract][Full Text] [Related]
23. NF-kappaB p105 is a target of IkappaB kinases and controls signal induction of Bcl-3-p50 complexes.
Heissmeyer V; Krappmann D; Wulczyn FG; Scheidereit C
EMBO J; 1999 Sep; 18(17):4766-78. PubMed ID: 10469655
[TBL] [Abstract][Full Text] [Related]
24. A short binding site in the KPC1 ubiquitin ligase mediates processing of NF-κB1 p105 to p50: A potential for a tumor-suppressive PROTAC.
Goldhirsh G; Kravtsova-Ivantsiv Y; Satish G; Ziv T; Brik A; Ciechanover A
Proc Natl Acad Sci U S A; 2021 Dec; 118(49):. PubMed ID: 34873064
[TBL] [Abstract][Full Text] [Related]
25. KPC1-mediated ubiquitination and proteasomal processing of NF-κB1 p105 to p50 restricts tumor growth.
Kravtsova-Ivantsiv Y; Shomer I; Cohen-Kaplan V; Snijder B; Superti-Furga G; Gonen H; Sommer T; Ziv T; Admon A; Naroditsky I; Jbara M; Brik A; Pikarsky E; Kwon YT; Doweck I; Ciechanover A
Cell; 2015 Apr; 161(2):333-47. PubMed ID: 25860612
[TBL] [Abstract][Full Text] [Related]
26. A20 inhibits both the degradation and limited processing of the NF-κB p105 precursor: A novel additional layer to its regulator role.
Lapid D; Lahav-Baratz S; Cohen S
Biochem Biophys Res Commun; 2017 Nov; 493(1):52-57. PubMed ID: 28923245
[TBL] [Abstract][Full Text] [Related]
27. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity.
Karin M; Ben-Neriah Y
Annu Rev Immunol; 2000; 18():621-63. PubMed ID: 10837071
[TBL] [Abstract][Full Text] [Related]
28. NFKB1: a suppressor of inflammation, ageing and cancer.
Cartwright T; Perkins ND; L Wilson C
FEBS J; 2016 May; 283(10):1812-22. PubMed ID: 26663363
[TBL] [Abstract][Full Text] [Related]
29. The NF-ĸB p50 subunit generated by KPC1-mediated ubiquitination and limited proteasomal processing, suppresses tumor growth.
Kravtsova-Ivantsiv Y; Goldhirsh G; Tomuleasa C; Pikarsky E; Ciechanover A
Cancer Cell Int; 2023 Apr; 23(1):67. PubMed ID: 37055826
[TBL] [Abstract][Full Text] [Related]
30. Expression, biological activities and mechanisms of action of A20 (TNFAIP3).
Verstrepen L; Verhelst K; van Loo G; Carpentier I; Ley SC; Beyaert R
Biochem Pharmacol; 2010 Dec; 80(12):2009-20. PubMed ID: 20599425
[TBL] [Abstract][Full Text] [Related]
31. Regulation and function of IKK and IKK-related kinases.
Häcker H; Karin M
Sci STKE; 2006 Oct; 2006(357):re13. PubMed ID: 17047224
[TBL] [Abstract][Full Text] [Related]
32. A20 inhibits NF-kappaB activation by dual ubiquitin-editing functions.
Heyninck K; Beyaert R
Trends Biochem Sci; 2005 Jan; 30(1):1-4. PubMed ID: 15653317
[TBL] [Abstract][Full Text] [Related]
33. Regulation and function of TPL-2, an IκB kinase-regulated MAP kinase kinase kinase.
Gantke T; Sriskantharajah S; Ley SC
Cell Res; 2011 Jan; 21(1):131-45. PubMed ID: 21135874
[TBL] [Abstract][Full Text] [Related]
34. The Tumor Suppressor Functions of Ubiquitin Ligase KPC1: From Cell-Cycle Control to NF-κB Regulator.
Gulei D; Drula R; Ghiaur G; Buzoianu AD; Kravtsova-Ivantsiv Y; Tomuleasa C; Ciechanover A
Cancer Res; 2023 Jun; 83(11):1762-1767. PubMed ID: 36880841
[TBL] [Abstract][Full Text] [Related]
35. A20 at the Crossroads of Cell Death, Inflammation, and Autoimmunity.
Martens A; van Loo G
Cold Spring Harb Perspect Biol; 2020 Jan; 12(1):. PubMed ID: 31427375
[TBL] [Abstract][Full Text] [Related]
36. CYLD, A20 and OTULIN deubiquitinases in NF-κB signaling and cell death: so similar, yet so different.
Lork M; Verhelst K; Beyaert R
Cell Death Differ; 2017 Jul; 24(7):1172-1183. PubMed ID: 28362430
[TBL] [Abstract][Full Text] [Related]
37. Zinc in human health: effect of zinc on immune cells.
Prasad AS
Mol Med; 2008; 14(5-6):353-7. PubMed ID: 18385818
[TBL] [Abstract][Full Text] [Related]
38. Regulators of A20 (TNFAIP3): new drug-able targets in inflammation.
Momtazi G; Lambrecht BN; Naranjo JR; Schock BC
Am J Physiol Lung Cell Mol Physiol; 2019 Mar; 316(3):L456-L469. PubMed ID: 30543305
[TBL] [Abstract][Full Text] [Related]
39. A20: A multifunctional tool for regulating immunity and preventing disease.
Malynn BA; Ma A
Cell Immunol; 2019 Jun; 340():103914. PubMed ID: 31030956
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]